• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
PALB2 Interest Group

PALB2 Interest Group

  • About
    • PALB2 gene
    • PALB2 mutation and cancer risks
    • A Study of Cancer Risks in PALB2 Mutation Carriers
    • Clinician Info
    • FAQs
  • Team
    • PALB2 Interest Group
    • Our Team
    • Our Collaborators
  • Resources
  • Publications
  • Events
  • Contact Us

New study shows that PARP inhibitors are effective in PALB2-related breast cancer

7th March 2026

Read more here

Category: News
Previous Post:5th annual PALB2 Carriers Information Session – 3rd December 2025 at 5-6pm London time
Next Post:PALB2 at 20 – should we now call it “BRCA3”

Our Researchers are funded by many organisations including:

European Research Council
Cancer Research UK

Copyright © 2026 · PALB2 Interest Group · All Rights Reserved